ストックスクリーナーアプリを入手
2.54
11.19%
-0.32
アフターアワーズ：
2.54
前日終値:
$2.86
開ける：
$2.77
24時間の取引高:
40,319
Relative Volume:
0.17
時価総額：
$3.40M
収益：
-
当期純損益:
$-38.35M
株価収益率:
-1.7517
EPS:
-1.45
ネットキャッシュフロー:
$-36.91M
1週間 パフォーマンス:
-25.73%
1か月 パフォーマンス:
-37.59%
6か月 パフォーマンス:
-78.25%
1年 パフォーマンス:
-86.08%
1日の値動き範囲:
$2.50
$2.78
1週間の範囲:
$2.50
$3.39
52週間の値動き範囲:
$2.50
$19.75
Galecto Inc Stock (GLTO) Company Profile
GLTO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GLTO
Galecto Inc
|
2.54 | 3.40M | 0 | -38.35M | -36.91M | -1.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 65.79B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 35.18B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 32.67B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Galecto Inc Stock (GLTO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-11-23 | 開始されました | BofA Securities | Buy |
| 2020-11-23 | 開始されました | Credit Suisse | Outperform |
| 2020-11-23 | 開始されました | SVB Leerink | Outperform |
Galecto Inc (GLTO) 最新ニュース
Galecto, Inc. Focuses on Oncology and Liver Diseases - TipRanks
Galecto stock hits 52-week low at $3.75 amid market challenges - Investing.com
Galecto stock hits 52-week low at $3.75 amid market challenges By Investing.com - Investing.com South Africa
Galecto stock hits 52-week low at $4.39 amid market challenges - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Galecto (GLTO) Shares Rally Amid Positive Market Momentum - Stocks Telegraph
Galecto Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Galecto Reports Full-Year 2024 Financial Results - The Manila Times
Galecto Cuts Losses by $17M, Acquires Promising AML Drug Candidate - StockTitan
Galecto Inc expected to post a loss of $2.97 a shareEarnings Preview - TradingView
Idiopathic Pulmonary Fibrosis Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, IND, NDA Approvals, Therapies, Mechanism of Action, Route of Administration & Companies by DelveInsight - The Globe and Mail
Galecto stock plunges to 52-week low at $3.76 amid market challenges - Investing.com Australia
Galecto (GLTO) Projected to Post Quarterly Earnings on Friday - Defense World
Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga
Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga
Galecto stock hits 52-week low at $4.20 amid market challenges - Investing.com Australia
Galecto stock hits 52-week low at $4.20 amid market challenges By Investing.com - Investing.com South Africa
Eterna Therapeutics (NASDAQ:ERNA) & Galecto (NASDAQ:GLTO) Head to Head Comparison - Defense World
Reviewing Eton Pharmaceuticals (NASDAQ:ETON) & Galecto (NASDAQ:GLTO) - Defense World
Galecto to Participate in Upcoming Investor Conferences - The Globe and Mail
Galecto stock hits 52-week low at $4.39 amid market challenges By Investing.com - Investing.com South Africa
Leerink Partnrs Estimates Galecto FY2024 Earnings - Defense World
Brokers Set Expectations for Galecto FY2029 Earnings - Armenian Reporter
Galecto to Participate in Upcoming Investor Conferences -February 06, 2025 at 08:01 am EST - Marketscreener.com
Biotech Spotlight: Galecto Lines Up Triple Conference Showcase for Investors - StockTitan
Where are the Opportunities in (GLTO) - Stock Traders Daily
Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga
Critical Analysis: Galecto (NASDAQ:GLTO) vs. ObsEva (NASDAQ:OBSV) - Defense World
(GLTO) On The My Stocks Page - Stock Traders Daily
Analyzing Galecto (NASDAQ:GLTO) and Pasithea Therapeutics (NASDAQ:KTTA) - Defense World
After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win - PharmaVoice
Galecto CEO Hans T. Schambye sells $7,509 in shares - Investing.com
Galecto (NASDAQ:GLTO) Shares Up 22.6% – Should You Buy? - Defense World
When (GLTO) Moves Investors should Listen - Stock Traders Daily
Galecto stock plunges to 52-week low at $4.78 amid market challenges - Investing.com Australia
Galecto stock hits 52-week low at $5.26 amid market challenges - Investing.com Nigeria
Galecto stock hits 52-week low at $5.26 amid market challenges By Investing.com - Investing.com South Africa
Galecto Inc (GLTO) 財務データ
収益
当期純利益
現金流量
EPS
Galecto Inc (GLTO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Firmani Lori | Interim CFO |
Jan 03 '25 |
Sale |
5.63 |
261 |
1,469 |
465 |
| Schambye Hans T. | Chief Executive Officer |
Jan 03 '25 |
Sale |
5.60 |
1,341 |
7,510 |
3,397 |
10.70%
大文字化:
|
ボリューム (24 時間):